The latest from Redeye about Scandinavian Life Science and Technology companies

Theme: Online Gambling

Get in the game and place your bets!

Find out more

Theme: Fight Cancer

There is a war on cancer and now, for the first time ever we see an opportunity for winning.

Find out more

Theme: Cybersecurity

Cyberattacks on the rise - Can we win the battle?

Find out more

Theme: Gaming

Super Investment Gaming Guide - In depths on the bits and pixels of the Gaming industry. GLHF

Find out more

Global Gaming 555

First comment on Q2

Research Note 2018-08-15
GLOBAL
icon-company Global Gaming 555

First comment on Q2

Research Note 2018-08-15 Johan Svantesson

This morning, Global Gaming published their Q2 report. Sales came in at nearly SEK 228m, which was largely in line with our estimate of SEK 220m. EBIT came in at SEK 41m and was thereby somewhat better than our expectations of approximately SEK 38m.

Continue reading

Episurf Medical

Stärker patentportföljen på global basis

Research Note 2018-08-15
EPIS B
icon-company Episurf Medical

Stärker patentportföljen på global basis

Research Note 2018-08-15 Anders Hedlund

Episurf Medical har under augusti månad beviljats patent i Australien och USA.

Continue reading

Sprint Bioscience

Fortsätter planenligt

Research Note 2018-08-15
SPRINT
icon-company Sprint Bioscience

Fortsätter planenligt

Research Note 2018-08-15 Arvid Necander

Sprint Bioscience rapporterade under morgonen resultatet från årets andra kvartal. Utvecklingen av portföljen fortsätter enligt plan och vi ser fram mot en förväntat händelserik andra halva av 2018.

Continue reading

PledPharma

Leverans av PledOx i september bekräftar tidsplan

Research Note 2018-08-15
PLED
icon-company PledPharma

Leverans av PledOx i september bekräftar tidsplan

Research Note 2018-08-14 Klas Palin

Tidigare rapporterade produktionsproblem (feb 2018) för PledOx har hanterats och leverans av prövningsläkemedel väntas ske under september. Därmed kan fas III-programmet komma i gång under Q4’18, vilket är i linje med vår förväntansbild.

Continue reading

Aspire Global

Interview with CEO Tsachi Maimon

Research Interview 2018-08-14
ASPIRE
icon-company Aspire Global

Interview with CEO Tsachi Maimon

Research Interview 2018-08-14 Johan Svantesson

Tsachi Maimon explains the strong development two main reasons during Q2; successful relationships with several big partners and bordering their offerings.

Continue reading

Neonode Inc

No sense of growth yet

Research Update 2018-08-15
icon-company Neonode Inc

No sense of growth yet

Research Update 2018-08-14 Viktor Westman

The outcome of Neonode's Q2 was once again considerably lower than our estimates.

Continue reading

Aspire Global

First comment on Q2

Research Note 2018-08-14
ASPIRE
icon-company Aspire Global

First comment on Q2

Research Note 2018-08-13 Johan Svantesson

Aspire Global showed an impressive Q2, where a solid performance from several partners and a strong offering were key drivers. Revenues came in at EUR 24.7, compared to our expectations of EUR 20.8m.

Continue reading

Nitro Games

Q2-estimate and comments about the game “HoW”

Research Note 2018-08-14
NITRO
icon-company Nitro Games

Q2-estimate and comments about the game “HoW”

Research Note 2018-08-14 Tomas Otterbeck

Since our last research update, Nitro Games has announced the company’s next game “Heroes of Warland” (HoW), secured marketing of the game and future cash flow in a directed issue and launched “Medals of War” in the MEA-region amongst other things.

Continue reading

ZetaDisplay

Inför Q2

Research Note 2018-08-14
ZETA
icon-company ZetaDisplay

Inför Q2

Research Note 2018-08-14 Johan Svantesson

Torsdagen den 16 augusti publicerar ZetaDisplay sin rapport för det andra kvartalet. Vi räknar med en hög omsättningstillväxt, vilken förväntas vara driven av genomförda förvärv.

Continue reading

Moberg Pharma

Extraordinarily strong 2Q18!

Research Update 2018-08-13
MOB
icon-company Moberg Pharma

Extraordinarily strong 2Q18!

Research Update 2018-08-13 Klas Palin

Moberg Pharma delivered strongly in 2Q18, driven by an impressive performance in its US OTC business. Following the 2Q18 earnings report, we are substantially raising our forecast, leading to an increase in our valuation.

Continue reading

Opus Group

Inför rapport

Research Note 2018-08-14
OPUS
icon-company Opus Group

Inför rapport

Research Note 2018-08-14 Henrik Alveskog

Halvårsrapporten släpps på fredag den 17 augusti. Det finns goda förutsättningar för att Q2 blir Opus starkaste kvartal hittills. Säkerligen intäktsmässigt och vi tror att även EBITDA hamnar på en ny toppnivå.

Continue reading

Cantargia

Uppdatering kring CANFOUR-studien

Research Note 2018-08-13
CANTA
icon-company Cantargia

Uppdatering kring CANFOUR-studien

Research Note 2018-08-13 Mathias Spinnars

Cantargia meddelar i dag en uppdatering kring fas I delen av CANFOUR, samt förberedelserna inför fas IIa.

Continue reading

Events

24

Aug

Xspray: Q2-presentation och Q&A

28

Aug

Early Bird

04

Sep

Early Bird

13

Sep

Investor After Work Malmö

20

Sep

Investor After Work Göteborg

25

Sep

Investor After Work Stockholm

Announcements

Redeye sponsrar integrationsprojektet Näringslivet Möter Förorten

Hitta nästa 1000-procentare på Redeye Growth Day

Redeye Corporate Finance söker projektledare med intresse för gaming och betting

You need to be a Redeye member to access this content

Become a member to:

By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions